Hepatic Inflammation Primes Vascular Dysfunction Following Treatment with LPS in a Murine Model of Pediatric Fatty Liver Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146802 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hong Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Research, Department of Pediatrics, University of Kentucky, Lexington, KY 40508, USA. Hauptthemen laut MEDLINE: Lipopolysaccharides, Liver, Inflammation, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association, Ohio Valley AHA, Department of Pediatrics.
Abstract (Originalsprache)
Obesity and pediatric fatty liver disease are increasingly prevalent, yet the underlying mechanisms linking these conditions to heightened inflammatory and immune responses remain poorly understood. Using a murine model reflecting early-life obesity and hepatic steatosis, we tested the hypothesis that obesity-driven hepatic inflammation intensifies systemic immune responses and exacerbates vascular dysfunction following innate immune activation. Newly weaned C57BL/6 mice were fed either a high-saturated-fat, high-cholesterol diet (HFD) or a control diet (CD) for four weeks, modeling adolescence in humans. HFD-fed mice exhibited hepatic and splenic enlargement, elevated plasma cholesterol levels, increased activity levels of liver enzymes (alanine and aspartate aminotransferases), and higher plasma serum amyloid A (SAA) concentrations. Following a sublethal dose of lipopolysaccharide (LPS), the expression of hepatic inflammatory genes (VCAM-1 and iNOS) was significantly elevated in HFD-fed mice, indicating an exaggerated local immune response. Mice fed an HFD also showed significant impairment in endothelium-dependent vasorelaxation compared to CD mice and saline-treated controls, while endothelium-independent responses remained intact. These vascular changes occurred in the context of hepatic inflammation, suggesting that early-life diet-induced steatosis sensitizes the vasculature to inflammatory insult. These findings suggest that obesity-driven hepatic inflammation primes exaggerated systemic immune responses to innate immune stimuli, potentially contributing to the vascular dysfunction and variable clinical morbidity observed in pediatric inflammatory conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Research, Department of Pediatrics, University of Kentucky, Lexington, KY 40508, USA.
- Division of Gastroenterology, Department of Pediatrics, University of Kentucky, Lexington, KY 40508, USA.
ORCID-Profile: Robin Shoemaker, Yasir Alsiraj
Förderung
- American Heart Association
- Ohio Valley AHA
- Department of Pediatrics
Zitieren
APA
Huang, H., Shoemaker, R., Alsiraj, Y., Murphy, M., Gibbons, T. E., & Bauer, J. A. (2025). Hepatic Inflammation Primes Vascular Dysfunction Following Treatment with LPS in a Murine Model of Pediatric Fatty Liver Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146802
Vancouver
Huang H, Shoemaker R, Alsiraj Y, Murphy M, Gibbons TE, Bauer JA. Hepatic Inflammation Primes Vascular Dysfunction Following Treatment with LPS in a Murine Model of Pediatric Fatty Liver Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146802
BibTeX
@article{Huang2025,
author = {Huang, Hong and Shoemaker, Robin and Alsiraj, Yasir and Murphy, Margaret and Gibbons, Troy E and Bauer, John A},
title = {Hepatic Inflammation Primes Vascular Dysfunction Following Treatment with LPS in a Murine Model of Pediatric Fatty Liver Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146802}
}
EUVIMED